Results 71 to 80 of about 58,659 (191)

Dynamics and Development of Extensively Drug-resistant Tuberculosis, Portugal [PDF]

open access: yes, 2012
Abstrat publicado em: http://www.pasteur.fr/infosci/conf/sb/tuberculosis2012/images/TB2012-Program-Abstract-book-LD.pdfThe development of multidrug-resistant (MDR) and extensive drug-resistant (XDR) tuberculosis(TB) combined with subsequent transmission ...
Couto, Isabel   +9 more
core  

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia

open access: yesEmerging Infectious Diseases, 2017
Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70% of multidrug-resistant and 96% of extensively drug-resistant Mycobacterium ...
Salim Allana   +11 more
doaj   +1 more source

In vitro and intracellular antimycobacterial activity of a Bacillus pumilus strain [PDF]

open access: yes, 2012
Despite the declaration of tuberculosis (TB) as a global emergency by the world health organization (WHO) about 20 years ago, the worldwide problem of this disease has worsened due to increased drug resistance of tuberculosis bacilli and acquired ...
David, Suzanna   +6 more
core   +1 more source

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives

open access: yesHIV/AIDS: Research and Palliative Care, 2020
Abhijeet Singh, 1 Rajendra Prasad, 1, 2 Viswesvaran Balasubramanian, 1 Nikhil Gupta 3 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, Delhi 110007, India; 2Department of Pulmonary Medicine, King ...
Singh A   +3 more
doaj  

Multidrug-resistant tuberculosis in Lithuania – Still a long way ahead

open access: yesMedicina, 2016
Despite the recent advances in the diagnosis of tuberculosis, treatment of the disease, for the most part, remains the same as it was half a century ago.
Greta Musteikienė   +4 more
doaj   +1 more source

GenoType® MTBDRsl assay for resistance to second-line anti-tuberculosis drugs [PDF]

open access: yes, 2016
Background Genotype® MTBDRsl (MTBDRsl) is a rapid DNA-based test for detecting specific mutations associated with resistance to fluoroquinolones and second-line injectable drugs (SLIDs) in Mycobacterium tuberculosis complex.
Dheda, Keertan   +5 more
core   +4 more sources

Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa

open access: yesEmerging Infectious Diseases, 2011
To determine whether women in KwaZulu-Natal, South Africa, with drug-resistant tuberculosis (TB) were more likely than men to have extensively drug-resistant TB, we reviewed 4,514 adults admitted during 2003–2008 for drug-resistant TB.
Max R. O’Donnell   +6 more
doaj   +1 more source

Point-of-care testing for disasters: needs assessment, strategic planning, and future design. [PDF]

open access: yes, 2009
Objective evidence-based national surveys serve as a first step in identifying suitable point-of-care device designs, effective test clusters, and environmental operating conditions.
Bangs   +44 more
core   +1 more source

Extensive Drug Resistance in Malaria and Tuberculosis

open access: yesEmerging Infectious Diseases, 2010
Drug resistance in malaria and in tuberculosis (TB) are major global health problems. Although the terms multidrug-resistant TB and extensively drug-resistant TB are precisely defined, the term multidrug resistance is often loosely used when discussing malaria.
Chansuda Wongsrichanalai   +4 more
openaire   +3 more sources

Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China [PDF]

open access: yes, 2012
China is one of the countries with the highest prevalence of fluoroquinolone-resistant (FQ r) Mycobacterium tuberculosis. Nevertheless, knowledge on the molecular characterization of the FQ r M.
Deng, G   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy